EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA
As listed in the register: EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA 200 mg/245 mg, comprimé pelliculé
300,70 mg + 200 mg · comprimé pelliculé
- Prescription only
- Active substance
- Succinate De Ténofovir Disoproxil + Emtricitabine
- Made by
- KRKA (SLOVENIE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | KRKA (SLOVENIE) |
|---|---|
| Active substance | Succinate De Ténofovir Disoproxil + Emtricitabine |
| Strength | 300,70 mg + 200 mg |
| Form | comprimé pelliculé |
| Route | orale |
| Dispensing (as stated by the register) | liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/16/1151 |
| Name in the register | EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA 200 mg/245 mg, comprimé pelliculé |
| Packs | plaquette(s) OPA : polyamide orienté aluminium polyéthylène DES de 28 comprimé(s) · 1 flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s) · 28 plaquette(s) OPA : polyamide orienté aluminium polyéthylène DES de 1 comprimé(s) · 3 flacons polyéthylène haute densité (PEHD) de 30 comprimé(s) |
| CIS | 65646855 |
| CIP13 | 3400930243183 |
| CIP13 | 3400930243190 |
| CIP13 | 3400930243213 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
See every product with Succinate De Ténofovir Disoproxil + Emtricitabine